INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
HJ
Harinstein JasonDirector
FNKOFunko, Inc.
Grant or award
A—
21.4K sh
Jun 3, 2026Jun 5, 2026
Page 723 of 1737
← PrevNext →
traded Jun 3, 2026
+2d
SEC Form 4

Evidence

9
BM
Briers Zachary MGeneral Counsel
SNAPSnap Inc
Open-market sale · 10b5-1 plan
SELL$72K
12.0K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

9
OY
Ong Chin YinChief Org Capability Officer
GRABGrab Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$131K
38.0K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
ZJ
Zheng Jie (James)Director, Chief Executive Officer
ASAmer Sports, Inc.
Option exercise
M—
500.0K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
MC
McDonough ClaireChief Financial Officer
RIVNRivian Automotive, Inc. / DE
Open-market sale · 10b5-1 plan
SELL$144K
8,022 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
LC
Long CaitlinDirector
CIFRCipher Digital Inc.
Grant or award
A—
8,299 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
MS
Milligan SandraDirector
GOSSGossamer Bio, Inc.
Grant or award
A—
115.0K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

9
LA
Lenz Robert A.Director
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
12.5K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
BG
Baker GailDirector
DRSLeonardo DRS, Inc.
Option exercise
M—
3,556 sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

9
SD
Schwartz DebraDirector
LMNDLemonade, Inc.
Grant or award
A—
2,848 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
CC
Calabria CarloDirector
ARQQArqit Quantum Inc.
Option exercise
M—
120.0K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
IT
Imran TalatDirector, Chief Executive Officer
RANIRani Therapeutics Holdings, Inc.
Grant or award
A—
3.80M sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
JA
Javadi AlirezaChief Technical Officer
RANIRani Therapeutics Holdings, Inc.
Grant or award
A—
805.5K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
RG
Ritchie GarthDirector
ARQQArqit Quantum Inc.
Option exercise
M—
73.6K sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

9
RA
Ricupati AgostinoVP Corp Controller & CAO
RKLBRocket Lab Corp
Grant or award
A—
27.5K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
KI
Kaul InderjitDirector
NERVMinerva Neurosciences, Inc.
Grant or award
A—
50.0K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
LR
Luse RebeccaDirector
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
10.0K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

9
RR
Ryan ReneeDirector
NPCENeuroPace Inc
Grant or award
A—
5,368 sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

9
HA
Hollister Kathryn ADirector
YOUClear Secure, Inc.
Option exercise
M—
6,741 sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

8
BA
Brady James AloysiusDirector
XERSXeris Biopharma Holdings, Inc.
Grant or award
A$203K
33.0K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

8
SM
Stepien Thomas MDirector, Chief Executive Officer
AMPXAmprius Technologies, Inc.
Gift
G—
30.4K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
1,313 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

8
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$502
143 sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

8
SM
Stepien Thomas MDirector, Chief Executive Officer
AMPXAmprius Technologies, Inc.
Gift
G—
36.9K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Other acquisition or disposition
J—
1,313 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

5
FM
Fischer Gregory MichaelDirector
SMTCSEMTECH CORP
Grant or award
A—
1,180 sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

5
FM
Fischer Gregory MichaelDirector
SMTCSEMTECH CORP
Option exercise
M—
5,321 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

3
VJ
Viana Antonio JDirector
AIPArteris, Inc.
Gift · 10b5-1 plan
G—
20.8K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

2
VE
Vivas EduardoDirector
APPAppLovin Corp
Grant or award
A—
525 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

1
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
8,064 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

0
PM
Persky MarlaDirector
XERSXeris Biopharma Holdings, Inc.
Grant or award · 10b5-1 plan
A—
24.2K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

0
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Option exercise · 10b5-1 plan
M—
8,064 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

0
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$900
100 sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence

0
VJ
Viana Antonio JDirector
AIPArteris, Inc.
Gift · 10b5-1 plan
G—
20.8K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

0
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Option exercise · 10b5-1 plan
M$40K
8,064 sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC Form 4

Evidence

0
PM
Persky MarlaDirector
XERSXeris Biopharma Holdings, Inc.
Grant or award · 10b5-1 plan
A$203K
33.0K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 5, 2026Jun 5, 2026
traded Jun 5, 2026
+0dSEC Form 4

Evidence